Document is current
Any future updates will be listed below
-
Authors
Szecskó, Anikó
Mészáros, Mária
Simões, Beatriz
Cavaco, Marco
Chaparro, Catarina
Porkoláb, Gergő
Castanho, Miguel A.R.B.
Deli, Mária A.
Neves, Vera
Veszelka, Szilvia
-
Funding
Funding for this research was provided by:
HUN-REN Biological Research Centre, Szeged
- License Information
-
More Information
Article History
Received: 30 August 2024
Accepted: 14 March 2025
First Online: 1 April 2025
Declarations
:
: The procedure of organ harvesting required to obtain primary cells from brain is exempt of animal experimentation permission based on the Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes.
: Not applicable.
: Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa owns a patent (WO2016120843A1) related to antibody molecules and peptide delivery systems for use in Alzheimer’s disease; V.N. and M.A.R.B.C. are named inventors. This patent was granted in the territories AU, CA, CN, EP, IN, JP, US. Additionally divisional/continuation patent applications covering peptides crossing brain endothelial cell layer are being pursued in the European and US regions and both are currently pending. Other authors declare no competing interest.
